JP2004520296A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520296A5
JP2004520296A5 JP2002549329A JP2002549329A JP2004520296A5 JP 2004520296 A5 JP2004520296 A5 JP 2004520296A5 JP 2002549329 A JP2002549329 A JP 2002549329A JP 2002549329 A JP2002549329 A JP 2002549329A JP 2004520296 A5 JP2004520296 A5 JP 2004520296A5
Authority
JP
Japan
Prior art keywords
alkyl
alkanoyl
alkanoylamino
amino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002549329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520296A (ja
JP4452017B2 (ja
Filing date
Publication date
Priority claimed from PCT/GB2000/004764 external-priority patent/WO2001044226A1/en
Priority claimed from GBGB0114185.2A external-priority patent/GB0114185D0/en
Application filed filed Critical
Publication of JP2004520296A publication Critical patent/JP2004520296A/ja
Publication of JP2004520296A5 publication Critical patent/JP2004520296A5/ja
Application granted granted Critical
Publication of JP4452017B2 publication Critical patent/JP4452017B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002549329A 2000-12-13 2001-12-12 セリンプロテアーゼインヒビター Expired - Fee Related JP4452017B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2000/004764 WO2001044226A1 (en) 1999-12-14 2000-12-13 Serine protease inhibitors
GBGB0114185.2A GB0114185D0 (en) 2001-06-12 2001-06-12 Compounds
PCT/GB2001/005526 WO2002047762A1 (en) 2000-12-13 2001-12-12 Serine protease inhibitors

Publications (3)

Publication Number Publication Date
JP2004520296A JP2004520296A (ja) 2004-07-08
JP2004520296A5 true JP2004520296A5 (cg-RX-API-DMAC7.html) 2010-02-12
JP4452017B2 JP4452017B2 (ja) 2010-04-21

Family

ID=9916341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002549329A Expired - Fee Related JP4452017B2 (ja) 2000-12-13 2001-12-12 セリンプロテアーゼインヒビター

Country Status (13)

Country Link
US (1) US7067516B2 (cg-RX-API-DMAC7.html)
EP (1) EP1343561B1 (cg-RX-API-DMAC7.html)
JP (1) JP4452017B2 (cg-RX-API-DMAC7.html)
KR (1) KR100814227B1 (cg-RX-API-DMAC7.html)
AT (1) ATE355101T1 (cg-RX-API-DMAC7.html)
AU (2) AU2220702A (cg-RX-API-DMAC7.html)
BR (1) BR0116166A (cg-RX-API-DMAC7.html)
CA (1) CA2436935C (cg-RX-API-DMAC7.html)
DE (1) DE60126978T2 (cg-RX-API-DMAC7.html)
ES (1) ES2282192T3 (cg-RX-API-DMAC7.html)
GB (1) GB0114185D0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03005254A (cg-RX-API-DMAC7.html)
WO (1) WO2002047762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
ES2275683T3 (es) * 2000-06-13 2007-06-16 Tularik Limited Inhibidores de la serino proteasa.
US7074934B2 (en) * 2000-06-13 2006-07-11 Tularik Limited Serine protease inhibitors
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
EP1753512B1 (en) 2004-05-28 2008-07-09 Nycomed GmbH Tetrahydropyridothiophenes
JP2008501768A (ja) 2004-06-11 2008-01-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の化合物及びテトラヒドロピリドチオフェンの使用
CA2576971A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
CA2596202A1 (en) 2005-02-09 2006-08-17 Altana Pharma Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
JP2008530053A (ja) 2005-02-11 2008-08-07 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン
AU2006251169A1 (en) 2005-05-25 2006-11-30 4Sc Ag Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A1 (en) 2005-05-25 2006-11-30 4Sc Ag Tetrahydropyridothiophenes for use in the treatment of cancer
AU2007207743B2 (en) * 2006-01-18 2010-07-08 Amgen Inc. Thiazole compounds as protein kinase B (PKB) inhibitors
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
US7897619B2 (en) 2007-07-17 2011-03-01 Amgen Inc. Heterocyclic modulators of PKB
AR075899A1 (es) * 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
MY162557A (en) 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
CN103435573B (zh) * 2013-07-16 2015-04-01 浙江医药高等专科学校 苄基取代的噻唑并环己烷类化合物、其制备方法和用途
CN103408541B (zh) * 2013-07-16 2015-04-01 浙江医药高等专科学校 吲哚取代的噻唑并环己烷类化合物、及其抗肿瘤用途
AU2014304562B8 (en) 2013-08-08 2018-07-05 Galapagos Nv Thieno[2,3-c]pyrans as CFTR modulators
PE20210097A1 (es) 2018-06-19 2021-01-12 Novartis Ag Derivados de tetrahidrotienopiridina n-sustituidos y sus usos
CN112566910B (zh) * 2018-06-21 2025-09-09 Ucb生物制药有限责任公司 用于治疗由IgE引起的疾病的噻吩衍生物
SG11202105190SA (en) * 2018-11-19 2021-06-29 11949098 Canada Inc 4,5,6,7-tetrahydro-l-benzothiophene modulators of retinoic acid receptor related (rar) orphan nuclear receptors (rors)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123986A (en) 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
WO1999011658A1 (en) * 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
WO1999055661A1 (en) 1998-04-24 1999-11-04 Proteus Molecular Design Limited Aminomethyl-benzoic ester derivatives as tryptase inhibitors
CA2375920A1 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
CA2383008A1 (en) * 1999-06-14 2000-12-21 Amanda Jane Lyons Compounds
GB9929552D0 (en) * 1999-12-14 2000-02-09 Proteus Molecular Design Compounds
AU2001264077B2 (en) * 2000-06-13 2006-08-10 Tularik Limited Serine protease inhibitors

Similar Documents

Publication Publication Date Title
JP2862375B2 (ja) Crfアンタゴニストとしてのピラゾロピリミジン
JP2002520316A5 (cg-RX-API-DMAC7.html)
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
HRP20090250T1 (hr) Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze
EP1400518A4 (en) DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTS
ATE315022T1 (de) Prostaglandinanaloga als ep4-rezeptoragonisten
PL377112A1 (pl) Sposoby wytwarzania związków pirolotriazynowych użytecznych jako inhibitory kinazy
JP2004516293A5 (cg-RX-API-DMAC7.html)
DK1720881T3 (da) 11-hydroxy-5h-(2,1-c)(1,4)benzodiazepin-5-on-derivater som nøglemellemprodukter i fremstilling afc2-substituerede pyrrolobenzodiazepiner
KR950018010A (ko) 단백질 키나제 c억제제
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
AR037465A1 (es) Compuesto derivado de 5-sulfanil-4h-1,2,4-triazol, composicion farmaceutica que lo comprende y proceso para su preparacion en fase liquida
MEP12608A (en) Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
DE602004031722D1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
WO2004013100A3 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
CA2421504A1 (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
JP2004504323A5 (cg-RX-API-DMAC7.html)
JP2002519408A5 (cg-RX-API-DMAC7.html)
PE20020524A1 (es) 7-oxo-piridopirimidinas como inhibidores de quinasas
WO2003075907A3 (en) Small molecule entry inhibitors
ATE550332T1 (de) 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
YU64901A (sh) Derivati bifenila
DE60013260D1 (de) Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellung